Nicorandil treatment improves survival and spatial learning in aged granulin knockout mice
Brain Pathology · 2025
DOI: 10.1111/bpa.13312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, 2025. Verfasst von Dana M Niedowicz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Nicorandil, Spatial Learning. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NCRR NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Mutations in the human granulin ( GRN ) gene are associated with multiple diseases, including dementia disorders such as frontotemporal dementia (FTD) and limbic‐predominant age‐related TDP‐43 encephalopathy (LATE). We studied a Grn knockout ( Grn ‐KO) mouse model in order to evaluate a potential therapeutic strategy for these diseases using nicorandil, a commercially available agonist for the ABCC9/Abcc9 ‐encoded regulatory subunit of the “K + ATP” channel that is well‐tolerated in humans. Aged (13 months) Grn ‐KO and wild‐type (WT) mice were treated as controls or with nicorandil (15 mg/kg/day) in drinking water for 7 months, then tested for neurobehavioral performance, neuropathology, and gene expression. Mortality was significantly higher for aged Grn ‐KO mice (particularly females), but there was a conspicuous improvement in survival for both sexes treated with nicorandil. Grn ‐KO mice performed worse on some cognitive tests than WT mice, but Morris Water Maze performance was improved with nicorandil treatment. Neuropathologically, Grn ‐KO mice had significantly increased levels of glial fibrillary acidic protein (GFAP)‐immunoreactive astrocytosis but not ionized calcium binding adaptor molecule 1 (IBA‐1)‐immunoreactive microgliosis, indicating cell‐specific inflammation in the brain. Expression of several astrocyte‐enriched genes, including Gfap , were also elevated in the Grn ‐KO brain. Nicorandil treatment was associated with a subtle shift in a subset of detected brain transcript levels, mostly related to attenuated inflammatory markers. Nicorandil treatment improved survival outcomes, cognition, and inflammation in aged Grn ‐KO mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
- Department of Pathology, University of Kentucky, Lexington, Kentucky, USA.
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.
- Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
- Department of Physiology, University of Kentucky, Lexington, Kentucky, USA.
ORCID-Profile: Dana M Niedowicz
Förderung
- NIA NIH HHS
- NCRR NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Niedowicz, D. M., Wang, W. X., Prajapati, P., Zhong, Y., Fister, S., Rogers, C. B., Sompol, P., Powell, D. K., Patel, I., Norris, C. M., Saatman, K. E., & Nelson, P. T. (2025). Nicorandil treatment improves survival and spatial learning in aged granulin knockout mice. Brain Pathology. https://doi.org/10.1111/bpa.13312
Vancouver
Niedowicz DM, Wang WX, Prajapati P, Zhong Y, Fister S, Rogers CB, et al. Nicorandil treatment improves survival and spatial learning in aged granulin knockout mice. Brain Pathology. 2025. doi:10.1111/bpa.13312
BibTeX
@article{Niedowicz2025,
author = {Niedowicz, Dana M and Wang, Wang-Xia and Prajapati, Paresh and Zhong, Yu and Fister, Shuling and Rogers, Colin B and Sompol, Pradoldej and Powell, David K and Patel, Indumati and Norris, Christopher M and Saatman, Kathryn E and Nelson, Peter T},
title = {Nicorandil treatment improves survival and spatial learning in aged granulin knockout mice},
journal = {Brain Pathology},
year = {2025},
doi = {10.1111/bpa.13312}
}
EUVIMED